GlassScriptPhysician profile
Bryan Velez Lopez
NPI 1619499563
$681.65
in general payments reported to CMS, 2019-2025
13 companies · $312 in 2025
The $312 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.83 · 2022: $100 · 2023: $180 · 2024: $56.88 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $129.90 | 2025 | |
| Glaxosmithkline, LLC. | $116.09 | 2023-2025 | Bexsero |
| Janssen Pharmaceuticals, INC | $100.00 | 2022 | |
| Genzyme Corporation | $81.86 | 2023 | |
| Seqirus USA INC | $76.33 | 2024-2025 | Flucelvax |
| Alk-Abello, INC | $38.85 | 2025 | Neffy, Grastek, Ragwitek |
| Cranial Technologies, INC | $37.24 | 2025 | Doc Band |
| Collegium Pharmaceutical, INC. | $20.14 | 2025 | Jornay Pm |
| Corium, LLC | $16.84 | 2024 | Azstarys |
| Sobi, INC | $16.78 | 2019 | |
| Sanofi Pasteur INC. | $16.22 | 2024 | |
| Bioverativ Therapeutics INC. | $16.05 | 2019 | |
| Merck Sharp & Dohme LLC | $15.35 | 2025 | Enflonsia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Velez Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.